Management of hematological malignancies during pregnancy |
| |
| Authors: | Tina Rizack Anthony Mega Robert Legare Jorge Castillo |
| |
| Affiliation: | 1. Division of Hematology and Oncology, The Miriam Hospital, The Warren Alpert Medical School of Brown University, Providence, Rhode Island;2. Department of Obstetrics and Gynecology and Division of Hematology and Oncology, Women and Infant's Hospital, The Warren Alpert Medical School of Brown University, Providence, Rhode Island |
| |
| Abstract: | The management of hematological malignancies during pregnancy is a challenging endeavor, which not only requires technical skills and knowledge by the clinicians but also requires sound clinical judgment and compassion, keeping in mind the patient and family preferences and, ultimately, the wellbeing of the neonate. The incidence of hematological malignancies during pregnancy is rare, ranging from 1 in 1,000 to 1 in 10,000 deliveries, impeding the design and execution of large prospective studies. The purpose of this review is to evaluate the limited existing data and make useful suggestions in the management of acute and chronic leukemias, Hodgkin and non‐Hodgkin lymphomas, plasma cell myeloma, and other hematological malignancies, such as myelodysplastic syndromes and hairy cell leukemia, during pregnancy. Am. J. Hematol. 2009. © 2009 Wiley‐Liss, Inc. |
| |
| Keywords: | |
|
|
